Context Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell CNTX and other ETFs, options, and stocks.

About CNTX

Context Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is dedicated to improving the lives of women living with cancer. It engages in developing advanced small molecule and immunotherapy treatments to transform care for hormone-driven breast and gynecological cancers. 

CEO
Martin A. Lehr
CEOMartin A. Lehr
Employees
12
Employees12
Headquarters
Philadelphia, Pennsylvania
HeadquartersPhiladelphia, Pennsylvania
Founded
2015
Founded2015
Employees
12
Employees12

CNTX Key Statistics

Market cap
56.29M
Market cap56.29M
Price-Earnings ratio
-1.91
Price-Earnings ratio-1.91
Dividend yield
—
Dividend yield—
Average volume
168.72K
Average volume168.72K
High today
$0.6776
High today$0.6776
Low today
$0.625
Low today$0.625
Open price
$0.6655
Open price$0.6655
Volume
190.12K
Volume190.12K
52 Week high
$2.75
52 Week high$2.75
52 Week low
$0.49
52 Week low$0.49

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own CNTX. This list is generated using Robinhood data, and it’s not a recommendation.
Lucid Group
AMC Entertainment
Ocugen, Inc
SNDL
Cenntro Inc.
Plug Power
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.